Soong, David
Stratford, Jeran
Avet-Loiseau, Herve
Bahlis, Nizar
Davies, Faith
Dispenzieri, Angela
Sasser, A. Kate
Schecter, Jordan M.
Qi, Ming
Brown, Chad
Jones, Wendell
Keats, Jonathan J.
Auclair, Daniel
Chiu, Christopher
Powers, Jason
Schaffer, Michael
Funding for this research was provided by:
Janssen Research & Development, LLC
Article History
Received: 28 June 2018
Accepted: 7 February 2020
First Online: 6 March 2020
Ethics approval and consent to participate
: Patient-level data from publicly available datasets (MMRF CoMMpass, TCGA prostate, TCGA AML) were analyzed. For POLLUX and CASTOR studies, all patients provided written consent and the trial protocols were approved by independent ethics committees or institutional review boards at each study center.
: Not applicable
: HA-L received honoraria from and served on a speakers bureau for Celgene, Amgen, Bristol-Myers Squibb, Sanofi, and Janssen; and received research funding from Celgene and Janssen. NB received honoraria and travel expenses from Celgene, Takeda, Janssen, and Amgen; served on advisory boards for Celgene, Takeda, Janssen, and Amgen; served on speakers bureaus for Celgene, Janssen, and Amgen; and received research funding from and provided expert testimony to Celgene and Janssen. FD received research funding from Janssen, and served on advisory boards for Amgen, Celgene, AbbVie, Novartis, and Bristol-Myers Squibb. AD received research funding from Celgene, Takeda, Pfizer, Alnylam, and Prothena. AKS is a former employee of Janssen and is currently employed at Genmab. DS, MS, JMS, MQ, and CC are employees of Janssen. DS and JMS hold stock and/or stock options in Johnson & Johnson. WJ, JP, and JS are employees of Q<sup>2</sup> Solutions, EA Genomics. CB is a former employee of Q<sup>2</sup> Solutions, EA Genomics and a current employee of Align Technology. JJK and DA do not have any competing interests to report.